EUVIMEDEUVIMED entdecken
Open Access

Atorvastatin mitigates memory deficits and brain monocyte infiltration in chronic hypercholesterolemia

Fengchao Gong, Qian Shi, Xiaojie Mou, Kang Wang, Qianqian Wang, Haitao Wang

Aging · 2023

DOI: 10.18632/aging.205217 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aging, 2023. Verfasst von Fengchao Gong und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The Second Affiliated Hospital of Shandong First Medical University, Tai'an 271000, Shandong, China. Hauptthemen laut MEDLINE: Hypercholesterolemia, Heptanoic Acids, Hyperlipidemias. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mild cognitive impairment (MCI) is a common symptom observed in people over 60 years old and is found to be aggravated by hypercholesterolemia. Severe neuroinflammation induced by BBB dysfunction and monocyte infiltration might be responsible for neuron damage and cognitive impairment. Atorvastatin is a lipid-lowering drug that is widely applied for the treatment of cardiovascular diseases. However, the potential function of Atorvastatin in hypercholesterolemia-induced MCI remains uncertain. Our research will explore the potential therapeutic function of Atorvastatin in memory deficits induced by chronic hypercholesterolemia. ApoE-/- mice were utilized to mimic the state of chronic hypercholesterolemia and were divided into four groups. Animals in the WT and ApoE-/-groups were orally administered with normal saline, while WT mice in the Atorvastatin group and ApoE-/- mice in the ApoE-/-+ Atorvastatin group were orally administered with 10 mg/kg/day Atorvastatin. Markedly increased plasma cholesterol levels reduced RI in the long-term memory test and the spatial short-term memory test, declined mobility in the open field test, and downregulated PSD-95 and BDNF were observed in ApoE-/- mice, all of which were signally reversed by Atorvastatin. Moreover, the percentages of brain Ly6Chi CD45+ cells and CD3+ CD45+ cells, as well as the blood Ly6Chi CD45+ cells, plasma IL-12/IL-23 levels and IL-17 level were found notably increased in ApoE-/- mice, all of which were largely repressed by Atorvastatin. Lastly, the increased BBB permeability, decreased ZO-1 and occludin levels, and reduced KLF2 level were markedly abolished by Atorvastatin. Collectively, Atorvastatin mitigated memory deficits and brain monocyte infiltration in ApoE-/- mice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypercholesterolemiaHeptanoic AcidsHyperlipidemiasHumansMiceAnimalsAtorvastatinMonocytesPyrrolesApolipoproteins EBrain

Stichwörter der Autor:innen

Atorvastatinchronic hypercholesterolemiacognitive impairmentmonocyte infiltration

Substanzen

AtorvastatinHeptanoic AcidsPyrrolesApolipoproteins E

Autor:innen und Institutionen

  • Department of Neurology, The Second Affiliated Hospital of Shandong First Medical University, Tai'an 271000, Shandong, China.
  • Department of Ultrasound, The Second Affiliated Hospital of Shandong First Medical University, Tai'an 271000, Shandong, China.

Zitieren

APA

Gong, F., Shi, Q., Mou, X., Wang, K., Wang, Q., & Wang, H. (2023). Atorvastatin mitigates memory deficits and brain monocyte infiltration in chronic hypercholesterolemia. Aging. https://doi.org/10.18632/aging.205217

Vancouver

Gong F, Shi Q, Mou X, Wang K, Wang Q, Wang H. Atorvastatin mitigates memory deficits and brain monocyte infiltration in chronic hypercholesterolemia. Aging. 2023. doi:10.18632/aging.205217

BibTeX
@article{Gong2023,
  author = {Gong, Fengchao and Shi, Qian and Mou, Xiaojie and Wang, Kang and Wang, Qianqian and Wang, Haitao},
  title = {Atorvastatin mitigates memory deficits and brain monocyte infiltration in chronic hypercholesterolemia},
  journal = {Aging},
  year = {2023},
  doi = {10.18632/aging.205217}
}
Kostenlos starten →